CRISPR relieves muscular dystrophy symptoms
The gene-editing technology has enjoyed success in treating dogs with the condition
CRISPR/CAS9 has been used in a study to relieve symptoms of muscular dystrophy in beagle puppies. The debilitating condition causes severe muscle weakness and degeneration and is caused by a genetic mutation. CRISPR/CAS9 is a revolutionary Dna-editing molecular tool that can repair genetic mutations, and for the first time it has been successful in treating the condition in a larger mammal. The research being carried out at the University of Texas is among the first to use the technology in an attempt to cure the disease. It’s hoped that the work will be a step towards treating humans with muscular dystrophy.
CRISPR/CAS9 can target genes and disable or repair them or insert new bits of DNA